FOMAT Medical Research has officially launched its new Phase I capabilities, marking a significant expansion in its service offerings. This milestone brings advanced early-phase clinical trial services to underserved communities, showcasing FOMAT’s commitment to innovation and diversity in clinical research. Expanding…
FOMAT Unveils Pioneering Phase 1 Capabilities: Championing Diversity in Clinical Trials and Enhancing Patient Care
Oxnard, CA- FOMAT Medical Research announced today the launch of its new Phase I capabilities. The expansion will enhance FOMAT’s ability to provide efficient and high-quality services to its clients in the pharmaceutical and biotech industries. The expanded capabilities will include…